PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Comprehensive Review

Volume 4 Issue 3

Possible Integrative Approaches to Treatments of Colon Cancer

Christina Rahm*

August 16, 2024

DOI : 10.56831/PSSRP-04-134

View PDF

Abstract

Colon cancer, which is also referred to as colorectal cancer, is an invasive and fatal disease that commences in the cells that line the colon or the rectum. This third most prevalent cancer among men and women has seen an increase in incidences and now constitutes a public health challenge. The American Cancer Society projected about 153,020 new cases in the U.S. alone and 52,550 mortalities in 2023 (American Cancer Society, 2023). Increases in incidence point out the need to develop new effective strategies that will help to improve treatment efficiency, leading to a better quality of patients' lives.

References

  1. American Cancer Society. (2023) “Cancer Facts & Figures 2023”. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2023.html
  2. Campbell PT., et al. “Associations of Recreational Physical Activity and Leisure Time Spent Sitting with Colorectal Cancer Survival”. Journal of Clinical Oncology 31.7 (2018): 876-885.
  3. Cohen SJ. (n.d.). Case Study: 58-year-old Man with Stage 4 Colon Cancer. https://www.cancertherapyadvisor.com/slideshow/clinical-quiz/case-study-58-year-old-man-with-stage-4-colon-cancer/
  4. Frugé AD., et al. “A Dietary Intervention High in Green Leafy Vegetables Reduces Oxidative DNA Damage in Adults at Increased Risk of Colorectal Cancer: Biological Outcomes of the Randomized Controlled Meat and Three Greens (M3G) Feasibility Trial”. Nutrients 13.4 (2021): 1220.
  5. Greenlee H., et al. “Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer”. Journal of the National Cancer Institute. Monographs 52 (2017): lgx012.
  6. He ZY., et al. “A systematic review and meta-analysis of the effect of curcumin on colorectal cancer in experimental and clinical studies”. Clinical and Translational Oncology 22.8 (2020): 1214-1225.
  7. Ketskés N and Rahm C. (n.d). Colon Cancer: A Case Study. ISNS Case Studies in Oncology.
  8. Labianca R., et al. “Colon cancer”. Critical reviews in oncology/hematology 74.2 (2010): 106-133.
  9. Le DT., et al. “PD-1 Blockade in Tumors with Mismatch-Repair Deficiency”. New England Journal of Medicine 372.26 (2015): 2509-2520.
  10. Markowitz SD., et al. “Focus on colon cancer”. Cancer cell 1.3 (2002): 233-236.
  11. National Cancer Institute. Integrative, Alternative, and Complementary Therapies (2021). https://www.cancer.gov/about-cancer/treatment/cam
  12. National Center for Complementary and Integrative Health (NCCIH). “Complementary, Alternative, or Integrative Health: What’s in a Name?" (2022). https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name
  13. National Center for Complementary and Integrative Health (NCCIH). “Cancer: In Depth”. (2022). https://www.nccih.nih.gov/health/cancer-in-depth
  14. National Comprehensive Cancer Network. “Distress Management, Version 3.2021”. (2021). https://www.nccn.org/professionals/physician_gls/pdf/distress.pdf
  15. Ojo OA., et al. “Anticancer Properties of Curcumin Against Colorectal Cancer: A Review”. Frontiers in Oncology 12 (2022): 881641.
  16. Pinquart M and Duberstein PR. “Depression and cancer mortality: A meta-analysis”. Psychological Medicine 40.11 (2010): 1797-1810.
  17. Sánchez-Fidalgo S., et al. “Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice”. Journal of Nutritional Biochemistry 66 (2019): 10-20.
  18. Sánchez-Fidalgo S., et al. “Polyphenols from Food and Natural Products: Neuroprotection and Safety”. Antioxidants 8.8 (2019): 361.
  19. Sauer R., et al. “Preoperative Versus Postoperative Chemoradiotherapy for Rectal Cancer”. New England Journal of Medicine 351.17 (2004): 1731-1740.
  20. Schmid D and Leitzmann MF. “Television Viewing and Time Spent Sedentary in Relation to Cancer Risk: A Meta-analysis”. Journal of the National Cancer Institute 106.7 (2014): dju098.
  21. Schmid D and Leitzmann MF. “Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis”. Annals of Oncology 25.7 (2014): 1293-1311.
  22. Shang F., et al. The inhibitory effects of probiotics on colon cancer cells: in vitro and in vivo studies. Journal Of Gastrointestinal Oncology 11.6 (2020): 1224-1232.
  23. Sun D., et al. “Recent progress in drug delivery”. Acta Pharmaceutica Sinica B 11.5 (2021): 1340-1356.
  24. Weitz J., et al. “Colorectal Cancer”. The Lancet 365.9454 (2005): 153-165.
  25. Wijewantha N., et al. “Targeting Colon Cancer Cells with Enzyme-Triggered Casein-Gated Release of Cargo from Mesoporous Silica-Based Nanoparticles”. Bioconjugate chemistry 32.11 (2021): 2353-2365.
  26. Winawer SJ., et al. “Randomized Comparison of Surveillance Intervals After Colonoscopic Removal of Newly Diagnosed Adenomatous Polyps”. New England Journal of Medicine 328.13 (1993): 901-906.
  27. Zhang M., et al. “Acupuncture for Symptom Management in Cancer Care: An Update”. Current Oncology Reports 21.6 (2019): 418.
  28. Zuo T., et al. “Gut mucosal virome alterations in ulcerative colitis”. Gut 68.7 (2019): 1169-1179.